RecruitingNot applicableNCT07682610

Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Health Services Research Intervention

This clinical trial studies statewide optimization of lung cancer screening (LCS) in Kentucky using the Quality Implementation of Lung Screening (QUILS™) System. Data from the Kentucky Cancer Registry shows that LCS implementation has contributed to a rapid decline in late-stage lung cancer diagnosis at twice the national average. Further, the declines are more than three times the national average decline in Kentucky's Central Appalachian region. Kentucky-based multilevel initiatives are needed to expand and accelerate this leading role and extend the LCS opportunity to more Kentuckians who are at increased risk of lung cancer. This trial may be able to accelerate optimal high-quality implementation of LCS utilizing the QUILS™ System and reduce the burden of lung cancer by assisting lung cancer screening programs located throughout Kentucky in implementing best practices in lung cancer screening by integrating the QUILS™ System domains and elements into their screening programs.

Checked against the public recordLast updated Jul 6, 2026 · Source: ClinicalTrials.gov

StatusRecruiting
PhaseNot applicable
U.S. locations17
SponsorTimothy Mullett
01
Study overview

What this study is about

Purpose
Health Services Research
Study type
Interventional
Phase
Not applicable
Sponsor
Timothy Mullett
Interventions being studied
Behavioral: Quality Implementation of Lung Cancer Screening (QUILS) System
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: * Member of a participating Lung Cancer Screening Program (LCSP) team or administrator * Willing to participate in the QUILS Index Assessment Survey process * Willing to participate in the QUILS Audit Feedback presentations * Willing to participate in formative evaluation interviews Exclusion Criteria: * Unwilling to participate in the QUILS Index Assessment Survey process * Unwilling to participate in the QUILS Audit Feedback presentations * Unwilling to participate in formative evaluation interviews

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • King's Daughter's Medical CenterAshland, Kentucky
  • Taylor Regional HospitalCampbellsville, Kentucky
  • St. Elizabeth HealthcareEdgewood, Kentucky
  • Georgetown Cancer Treatment CancerGeorgetown, Kentucky
  • TJ Samson Community HospitalGlasgow, Kentucky
  • Hazard Appalachian Regional Healthcare Medical CenterHazard, Kentucky
  • Lexington VA Health Care SystemLexington, Kentucky
  • St. Joseph Health (Catholic Health Initiatives)Lexington, Kentucky
  • University of Kentucky Markey Cancer CenterLexington, Kentucky
  • The James Graham Brown Cancer Center at University of LouisvilleLouisville, Kentucky
  • Meadowview Regional Medical CenterMaysville, Kentucky
  • Saint Claire Regional Medical CenterMorehead, Kentucky

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 6, 2026. Always confirm current availability with the study team.

View original record ↗